ORIC
NASDAQ · Biotechnology
Oric Pharmaceuticals Inc
$9.12
+0.19 (+2.13%)
Open$8.80
Previous Close$8.93
Day High$9.13
Day Low$8.80
52W High$14.93
52W Low$7.23
Volume—
Avg Volume1.72M
Market Cap878.86M
P/E Ratio—
EPS$-1.43
SectorBiotechnology
Analyst Ratings
Strong Buy
22 analysts
Price Target
+473.0% upside
Current
$9.12
$9.12
Target
$52.26
$52.26
$31.55
$52.26 avg
$71.26
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 151.33M | 156.80M | 123.33M |
| Net Income | -16,895,209 | -20,414,835 | -15,522,009 |
| Profit Margin | -11.2% | -13.0% | -12.6% |
| EBITDA | -22,168,918 | -26,679,727 | -20,408,682 |
| Free Cash Flow | -10,591,679 | -9,966,569 | -9,555,180 |
| Rev Growth | +7.8% | +20.1% | +4.2% |
| Debt/Equity | 0.36 | 0.45 | 0.43 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.89 | +0.06% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $351.43 | +1.27% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.16 | +0.09% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $475.20 | +1.45% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $623.43 | +0.87% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $294.06 | +2.04% | 64.3 | 37.13B |